Diana Rivers

Array ( [id] => 2777036 [patent_doc_number] => 05151429 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-09-29 [patent_title] => '17.beta.-acyl-4-aza-5.alpha.-androst-1-ene-3-ones as 5.alpha. reductase inhibitors' [patent_app_type] => 1 [patent_app_number] => 7/764047 [patent_app_country] => US [patent_app_date] => 1991-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2869 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/151/05151429.pdf [firstpage_image] =>[orig_patent_app_number] => 764047 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2777054 [patent_doc_number] => 05151430 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-09-29 [patent_title] => 'Specific 17.beta.-thiobenzoyl-4-aza-5.alpha.-androst-1-en-3-ones as antiandrogen agents' [patent_app_type] => 1 [patent_app_number] => 7/745659 [patent_app_country] => US [patent_app_date] => 1991-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4741 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/151/05151430.pdf [firstpage_image] =>[orig_patent_app_number] => 745659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2937878 [patent_doc_number] => 05190947 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-03-02 [patent_title] => 'Codeine salt of a substituted carboxylic acid, its use and pharmaceutical compositions thereof' [patent_app_type] => 1 [patent_app_number] => 7/746676 [patent_app_country] => US [patent_app_date] => 1991-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3702 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/190/05190947.pdf [firstpage_image] =>[orig_patent_app_number] => 746676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2783451 [patent_doc_number] => 05164390 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-11-17 [patent_title] => '6-substituted purinyl piperazine derivatives' [patent_app_type] => 1 [patent_app_number] => 7/724621 [patent_app_country] => US [patent_app_date] => 1991-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16417 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 334 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/164/05164390.pdf [firstpage_image] =>[orig_patent_app_number] => 724621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2844494 [patent_doc_number] => 05138063 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-08-11 [patent_title] => '17.beta.-methoxycarbonyl-4-aza-androsten-1-en-3-ones' [patent_app_type] => 1 [patent_app_number] => 7/701332 [patent_app_country] => US [patent_app_date] => 1991-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3174 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/138/05138063.pdf [firstpage_image] =>[orig_patent_app_number] => 701332 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2785575 [patent_doc_number] => 05155098 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-10-13 [patent_title] => 'N-heteroaryl-purin-6-amines, and pharmaceutical compositions and methods employing them' [patent_app_type] => 1 [patent_app_number] => 7/696472 [patent_app_country] => US [patent_app_date] => 1991-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7392 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 148 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/155/05155098.pdf [firstpage_image] =>[orig_patent_app_number] => 696472 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2832840 [patent_doc_number] => 05175291 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-12-29 [patent_title] => 'Process for preparing 1,3-dipropyl-8-(3-oxocyclopentyl)-xanthine' [patent_app_type] => 1 [patent_app_number] => 7/691193 [patent_app_country] => US [patent_app_date] => 1991-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8810 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/175/05175291.pdf [firstpage_image] =>[orig_patent_app_number] => 691193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2835740 [patent_doc_number] => 05120742 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-06-09 [patent_title] => '17 .beta.-acyl-4-aza-5 .alpha.-androst-1-ene-3-ones as 5 .alpha.-reductase inhibitors' [patent_app_type] => 1 [patent_app_number] => 7/683520 [patent_app_country] => US [patent_app_date] => 1991-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3405 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/120/05120742.pdf [firstpage_image] =>[orig_patent_app_number] => 683520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2816753 [patent_doc_number] => 05122606 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-06-16 [patent_title] => '10,11-methylenedioxy camptothecins' [patent_app_type] => 1 [patent_app_number] => 7/666181 [patent_app_country] => US [patent_app_date] => 1991-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5008 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/122/05122606.pdf [firstpage_image] =>[orig_patent_app_number] => 666181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2815210 [patent_doc_number] => 05122526 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-06-16 [patent_title] => 'Camptothecin and analogs thereof and pharmaceutical compositions and method using them' [patent_app_type] => 1 [patent_app_number] => 7/636252 [patent_app_country] => US [patent_app_date] => 1990-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 2 [patent_no_of_words] => 12753 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/122/05122526.pdf [firstpage_image] =>[orig_patent_app_number] => 636252 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2910544 [patent_doc_number] => 05227380 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-07-13 [patent_title] => 'Pharmaceutical compositions and methods employing camptothecins' [patent_app_type] => 1 [patent_app_number] => 7/636150 [patent_app_country] => US [patent_app_date] => 1990-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12767 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/227/05227380.pdf [firstpage_image] =>[orig_patent_app_number] => 636150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2847143 [patent_doc_number] => 05110818 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-05-05 [patent_title] => 'Anticonvulsive substituted-9-benzyl-9H-purines' [patent_app_type] => 1 [patent_app_number] => 7/630401 [patent_app_country] => US [patent_app_date] => 1990-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14600 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/110/05110818.pdf [firstpage_image] =>[orig_patent_app_number] => 630401 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2948972 [patent_doc_number] => 05180824 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-01-19 [patent_title] => '6-azido-2-fluoropurine, useful in the synthesis of nucleosides' [patent_app_type] => 1 [patent_app_number] => 7/620236 [patent_app_country] => US [patent_app_date] => 1990-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3830 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/180/05180824.pdf [firstpage_image] =>[orig_patent_app_number] => 620236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2909668 [patent_doc_number] => RE034185 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-02-23 [patent_title] => 'Stabilization of non-aqueous solutions of 3-isothiazolones' [patent_app_type] => 2 [patent_app_number] => 7/606222 [patent_app_country] => US [patent_app_date] => 1990-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2046 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/034/RE034185.pdf [firstpage_image] =>[orig_patent_app_number] => 606222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2947014 [patent_doc_number] => 05180722 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-01-19 [patent_title] => '10,11-methylenedioxy-20(RS)-camptothecin and 10,11-methylenedioxy-20(S)-camptothecin analogs' [patent_app_type] => 1 [patent_app_number] => 7/581916 [patent_app_country] => US [patent_app_date] => 1990-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9491 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/180/05180722.pdf [firstpage_image] =>[orig_patent_app_number] => 581916 [rel_patent_id] =>[rel_patent_doc_number] =>)